PRCT logo

PROCEPT BioRobotics (PRCT) EBITDA

Annual EBITDA

-$101.90 M
-$22.77 M-28.78%

December 31, 2023


Summary


Performance

PRCT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRCTprofitabilitymetrics:

Quarterly EBITDA

-$18.51 M
+$4.82 M+20.67%

September 30, 2024


Summary


Performance

PRCT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRCTprofitabilitymetrics:

TTM EBITDA

-$90.62 M
+$4.04 M+4.27%

September 30, 2024


Summary


Performance

PRCT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRCTprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

PRCT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.8%+26.2%+7.6%
3 y3 years-127.0%+26.2%+7.6%
5 y5 years-156.3%+26.2%+7.6%

PRCT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.9%at low-23.8%+31.0%-78.7%+9.1%
5 y5-year-156.3%at low-86.8%+31.0%-814.8%+9.1%
alltimeall time-156.3%at low-86.8%+31.0%-814.8%+9.1%

PROCEPT BioRobotics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$18.51 M(-20.7%)
-$90.62 M(-4.3%)
Jun 2024
-
-$23.33 M(-1.7%)
-$94.67 M(-0.4%)
Mar 2024
-
-$23.73 M(-5.3%)
-$95.02 M(-3.1%)
Dec 2023
-$101.90 M(+28.8%)
-$25.06 M(+11.1%)
-$98.09 M(-1.6%)
Sep 2023
-
-$22.55 M(-4.8%)
-$99.67 M(+2.1%)
Jun 2023
-
-$23.68 M(-11.7%)
-$97.58 M(+7.3%)
Mar 2023
-
-$26.80 M(+0.6%)
-$90.93 M(+15.0%)
Dec 2022
-$79.13 M
-$26.64 M(+30.3%)
-$79.07 M(+15.3%)
Sep 2022
-
-$20.45 M(+20.1%)
-$68.57 M(+14.4%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$17.03 M(+13.9%)
-$59.95 M(+8.6%)
Mar 2022
-
-$14.95 M(-7.4%)
-$55.22 M(+8.9%)
Dec 2021
-$50.72 M(+13.0%)
-$16.14 M(+36.4%)
-$50.72 M(+7.1%)
Sep 2021
-
-$11.84 M(-3.7%)
-$47.37 M(+4.3%)
Jun 2021
-
-$12.29 M(+17.7%)
-$45.44 M(+37.1%)
Mar 2021
-
-$10.44 M(-18.4%)
-$33.14 M(+46.0%)
Dec 2020
-$44.90 M(+12.9%)
-$12.79 M(+29.1%)
-$22.70 M(+129.1%)
Sep 2020
-
-$9.91 M
-$9.91 M
Dec 2019
-$39.76 M
-
-

FAQ

  • What is PROCEPT BioRobotics annual EBITDA?
  • What is the all time high annual EBITDA for PROCEPT BioRobotics?
  • What is PROCEPT BioRobotics annual EBITDA year-on-year change?
  • What is PROCEPT BioRobotics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for PROCEPT BioRobotics?
  • What is PROCEPT BioRobotics quarterly EBITDA year-on-year change?
  • What is PROCEPT BioRobotics TTM EBITDA?
  • What is the all time high TTM EBITDA for PROCEPT BioRobotics?
  • What is PROCEPT BioRobotics TTM EBITDA year-on-year change?

What is PROCEPT BioRobotics annual EBITDA?

The current annual EBITDA of PRCT is -$101.90 M

What is the all time high annual EBITDA for PROCEPT BioRobotics?

PROCEPT BioRobotics all-time high annual EBITDA is -$39.76 M

What is PROCEPT BioRobotics annual EBITDA year-on-year change?

Over the past year, PRCT annual EBITDA has changed by -$22.77 M (-28.78%)

What is PROCEPT BioRobotics quarterly EBITDA?

The current quarterly EBITDA of PRCT is -$18.51 M

What is the all time high quarterly EBITDA for PROCEPT BioRobotics?

PROCEPT BioRobotics all-time high quarterly EBITDA is -$9.91 M

What is PROCEPT BioRobotics quarterly EBITDA year-on-year change?

Over the past year, PRCT quarterly EBITDA has changed by +$6.55 M (+26.16%)

What is PROCEPT BioRobotics TTM EBITDA?

The current TTM EBITDA of PRCT is -$90.62 M

What is the all time high TTM EBITDA for PROCEPT BioRobotics?

PROCEPT BioRobotics all-time high TTM EBITDA is -$9.91 M

What is PROCEPT BioRobotics TTM EBITDA year-on-year change?

Over the past year, PRCT TTM EBITDA has changed by +$7.47 M (+7.62%)